ASH 2024 Summary: MPN Highlights and Clinical Implications

2024 ASH Annual Meeting Insights Hub

D. Tremblay

Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Diagnosis of Thalassemia: Molecular, Lab-Based, and Iron-Based Testi…

Sean Campbell

Monitoring Guidelines for Thalassemia Syndromes

Farrukh Shah

Principles of Iron Management in Thalassemia

Nita Radhakrishnan

Year in Review 2024 - Highlights in MPNs and Impact on Practice

Oncology 2024 Year in Review

P. Bose

Laboratory Evaluation and Diagnosis of Thalassemia

Norafiza Mohd Yasin

How I Treat Anemia in Myelofibrosis

Cleveland Clinic Taussig Cancer Institute

A. Jain

ASH 2024 Summary: Overview of Non-Surgical Management of Heavy Menst…

2024 ASH Annual Meeting Insights Hub

A. Wheeler

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatmen…

Stefan Eber

Identifying and Treating Iron Deficiency in Pregnancy

Steven Fein

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

ASH 2024 Summary: Survival Outcomes in Patients With MF & New or Wor…

2024 ASH Annual Meeting Insights Hub

A. Kuykendall

Laboratory Diagnosis of Thalassemia

Gunay Aliyeva